Clinical research over the last two decades showing small-fiber atrophy in the tongue and increased expression of TRPV1 and purinergic receptors (P2X3) ion channels in the epithelium of the lingual mucosa of BMS patients suggest a neuropathic component in BMS (227–230). The gene discussed is P2RX3; the disease is burning mouth syndrome.